BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 27231347)

  • 41. NF-Y recruits both transcription activator and repressor to modulate tissue- and developmental stage-specific expression of human γ-globin gene.
    Zhu X; Wang Y; Pi W; Liu H; Wickrema A; Tuan D
    PLoS One; 2012; 7(10):e47175. PubMed ID: 23071749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation.
    Vocadlo DJ
    Curr Opin Chem Biol; 2012 Dec; 16(5-6):488-97. PubMed ID: 23146438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
    El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
    Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fatty acid synthase inhibits the
    Groves JA; Maduka AO; O'Meally RN; Cole RN; Zachara NE
    J Biol Chem; 2017 Apr; 292(16):6493-6511. PubMed ID: 28232487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability.
    Authier F; Ondruskova N; Ferenbach AT; McNeilly AD; van Aalten DMF
    Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38566589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
    Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
    Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential role of O-GlcNAc modification in cancer epigenetics.
    Forma E; Jóźwiak P; Bryś M; Krześlak A
    Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
    Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
    J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-GlcNAc transferase associates with the MCM2-7 complex and its silencing destabilizes MCM-MCM interactions.
    Leturcq M; Mortuaire M; Hardivillé S; Schulz C; Lefebvre T; Vercoutter-Edouart AS
    Cell Mol Life Sci; 2018 Dec; 75(23):4321-4339. PubMed ID: 30069701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Muha V; Fenckova M; Ferenbach AT; Catinozzi M; Eidhof I; Storkebaum E; Schenck A; van Aalten DMF
    J Biol Chem; 2020 Jun; 295(26):8636-8646. PubMed ID: 32094227
    [No Abstract]   [Full Text] [Related]  

  • 53. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
    Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Excessive
    Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
    Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects.
    Lanza C; Tan EP; Zhang Z; Machacek M; Brinker AE; Azuma M; Slawson C
    Cell Cycle; 2016 May; 15(10):1363-75. PubMed ID: 27070276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
    Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
    Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Removal of O-GlcNAcylation is important for pig preimplantation development.
    Shibutani M; Mori T; Miyano T; Miyake M
    J Reprod Dev; 2015; 61(4):341-50. PubMed ID: 26004176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.
    Keembiyehetty C; Love DC; Harwood KR; Gavrilova O; Comly ME; Hanover JA
    J Biol Chem; 2015 Mar; 290(11):7097-113. PubMed ID: 25596529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in
    Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
    J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.